NASDAQ:LBRX | Income Statement | LB PHARMACEUTICALS INC

Complete source-backed income-statement history.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$44.15M$53.92M$2.31M-$51.6M$0.00-$51.6M-$1.71-$1.7130,137,73330,137,733
2026-03-31$14.65M$22.1M$3.05M-$19.05M$0.00-$19.05M-$0.67-$0.6728,241,70128,241,701
2025-12-31$8.48M$13.87M$2.4M-$11.47M$1,000.00-$11.47M$3.13$3.135,849,9465,849,946
2025-09-30$2.42M$5.25M$1.69M-$3.56M$0.00-$3.56M-$0.61-$0.615,806,8625,806,862
2025-06-30$2.42M$4.86M-$12,000.00-$4.87M$0.00-$4.87M-$13.58-$13.58358,811358,811
2025-03-31$3.42M$6.43M$1.12M-$5.31M$0.00-$5.31M-$14.79-$14.79358,777358,777
2024-12-31$376,000.00$5.54M$469,000.00-$5.07M$1,000.00-$5.07M-$14.00-$14.00338338
2024-09-30$10.66M$16.08M$1.9M-$14.18M$0.00-$14.18M-$39.49-$39.49359,079359,079
2024-06-30-$27.63M
2024-03-31-$16.22M

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$16.74M$30.4M$5.2M-$25.2M$1,000.00-$25.21M-$3.13-$3.138,045,1458,045,145
2024-12-31$51.17M$64.83M$1.73M-$63.1M$1,000.00-$63.1M-$176.15-$176.15358,229358,229